Advertisement

Topics

Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $3500

16:06 EST 8 Nov 2017 | BioPortfolio Report Blog

Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 Pipeline Review, H2 2017


Summary


Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 Histone deacetylase 8 is an enzyme encoded by the HDAC8 gene. It is responsible for the deacetylation of lysine residues on the Nterminal part of the core histones. It plays an important role in transcriptional regulation, cell cycle progression and developmental events.


Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 pipeline Target constitutes close to 7 molecules. Out of which approximately 7 molecules are developed by Companies. The molecules developed by companies in Phase III, Preclinical and Unknown stages are 1, 5 and 1 respectively. Report covers products from therapy areas Oncology, Central Nervous System, Gastrointestinal, Infectious Disease and Musculoskeletal Disorders which include indications Breast Cancer, Colon Cancer, NonSmall Cell Lung Cancer, Pancreatic Cancer, Prostate Cancer, Adenoid Cystic Carcinoma ACC, BCell NonHodgkin Lymphoma, Bladder Cancer, Bone Disorders, Brain Cancer, Cognitive Disorders, Colorectal Cancer, Diffuse Large BCell Lymphoma, Follicular Lymphoma, Human Immunodeficiency Virus HIV Infections AIDS, Liver Cancer, Liver Fibrosis, Lung Cancer, Mantle Cell Lymphoma, Marginal Zone Bcell Lymphoma, Melanoma, Neurodegenerative Diseases, NonHodgkin Lymphoma, Peripheral TCell Lymphomas PTCL, Renal Cell Carcinoma and TCell Leukemia.


The latest report Histone Deacetylase 8 Pipeline Review, H2 2017, outlays comprehensive information on the Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type. It also reviews key players involved in Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 targeted therapeutics development with respective active and dormant or discontinued projects.


The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98

The report reviews Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 targeted therapeutics and enlists all their major and minor projects

The report assesses Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Histone Deacetylase 8 Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98 Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...